期刊文献+

血清胱抑素C浓度变化对于慢性心力衰竭患者的临床评价意义 被引量:8

Clinical evaluation of serum cystatin C concentrations for patients with chronic heart failure
下载PDF
导出
摘要 目的探讨血清胱抑素C(cystatin,Cys-C)对慢性心力衰竭(CHF)患者的临床评价意义。方法选择2010年7~12月在我院心内科住院的心脏病患者114例,并将其分为A、B、C 3组。A组64例为CHF患者(无原发性肾脏疾病),B组50例为无心力衰竭的心脏病患者,C组58例为健康志愿者。分别测定A、B、C 3组患者Cys-C、血清肌酐(SCr)、尿素氮(BUN)及血清β2-微球蛋白(β2-MG)水平,并进行统计分析。结果 A组与B、C组相比,血Cys-C浓度明显升高(P<0.01),其中心功能Ⅲ、Ⅳ级的血清浓度高于Ⅰ~Ⅱ级(P<0.05);不同病因心力衰竭组相互比较,血CysC浓度差异无统计学意义;血Cys-C与年龄成正相关,与左心射血分数(LVEF)、B型尿钠肽(BNP)水平呈负相关。结论血Cys-C浓度反映CHF患者的早期肾功能损害,可能是心力衰竭恶化的早期指标之一,是评估CHF风险预后的有效指标。 Objective To discuss clinical evaluation of serum cystatin C(Cystatin,Cys-C) concentrations for patients with CHF(Chronic Heart Failure). Methods 114 patients with heart disease in the Cardiology Department of our hospital from July 2010 to December 2010 were chosen and divided into three groups.Patients in Group A(n=64) had chronic heart failure(no primary renal disease),Group B(n=50) patients without heart failure,and Group C(n=58) healthy volunteers as control group.Cys-C,serum creatinine (SCr),blood urea nitrogen(Bun) and serum β2-microglobulin(β2-MG) levels of the three groups were measured respectively,and statistical analysis was done as well.Results Compared with Group B and C,serum CysC concentrations of Group A were significantly increased(P0.01),its heart function Ⅲ,Ⅳ grade was higher than the serum concentrations of Ⅰ~Ⅱ level(P0.05).The causes of groups with different heart failure were compared and concentrations of CysC had no significant differences.CysC was positively correlated with age and LVEF,and BNP levels were negatively correlated.Conclusion CysC concentration reflects early renal damage of patients with CHF,and is an early indicator of deteriorating heart failure.It is also an effective indicator to assess the prognosis of CHF risk.
作者 李学知 朱莉
出处 《实用临床医药杂志》 CAS 2011年第9期40-42,46,共4页 Journal of Clinical Medicine in Practice
关键词 心力衰竭 充血性 胱抑素C 血肌酐 heart failure congestive cystatin C serum creatinine
  • 相关文献

参考文献14

  • 1Marenzi G,Lauri G,Guazzi M,et al.Cardiac and renal dysfunction in chronic heart failure:relation to neurohumoral activation and pro-gnosis[J].AmJMedSci,2001,321(6):359.
  • 2Filler G,Bokenkamp,Hofmann W,et al.CystatinC as a marker of GFR history,indications,and future research[J].Clin Biochem,2005,38(1):1.
  • 3王生余,曾彩虹,刘志红.血清胱抑素C——评价肾功能的新指标[J].肾脏病与透析肾移植杂志,2006,15(4):366-370. 被引量:40
  • 4林礼兴,雷焕英,林丽婷.血清中胱抑素C测定对评价肾小球滤过功能的重要价值[J].临床和实验医学杂志,2006,5(7):1010-1011. 被引量:42
  • 5Gokkusu C A,Ozden T A,GulH,et al.1 Relationship between pla-sma cystatin C and creatinine in chronic renal diseases and Tx2 tran-splant patients[J].Clin Biochem,2004,37(2):942.
  • 6Coll E,Botey A.Serum cystatin C as a new market for noninvasi-ive estimation of glomerular filt ration rate and as a market for early renal impairment[J].Am J Kidney Dis,2000,36(1):29.
  • 7李玉艳,杨振坤,李强.胱抑素C在临床中的应用进展[J].国际检验医学杂志,2006,27(9):812-813. 被引量:106
  • 8Maxywell A P,Ong H Y,Nicholls D P.Influence of progressive renal dysfunction in chronic heart failure[J].Eur J Heart Fail,2002,4(2):125.
  • 9Neumann J,Ligtenberg G,Klein II,et al.Sympathetic hyperactivity in chronic kidney disease:pathogenesis,clinical relevance,and treatment[J].Kidney Int,2004,65(5):1568.
  • 10Randers E J,Erlandsen O L,Pedersen C,et al.Serum cystatinC as an endogenous parameter of the renalfunction in patients with normal to moderately impaired kidney function[J].Clin Nphr,2000,54(3):203.

二级参考文献51

  • 1Zore I, Krasovec M, Cimerman N, et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem, 2001, 382(5): 805-810.
  • 2Takeuchi M, Fukuda Y, Nakano I, et al. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol, 2001, 13(8): 951-955.
  • 3Domej W, Tilz GP, Foldes-Papp Z, et al. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies. Clin Sci (Lond), 2002, 102 (3) :373-380.
  • 4Mannes AJ, Martin BM, Yang HY, et al. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain,2003, 102(3): 251-256.
  • 5Eisenach JC, Thomas JA, Rauck RL, et al. Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans. Pain, 2004, 107(3): 207-212.
  • 6Gupta-Malhotra M, Levine DM, Cooper RS, et al. Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of kawasaki disease. Cardiology, 2003, 99(3): 121-125.
  • 7Gokkusu CA, Ozden TA, Gul H, et al. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem, 2004, 37(2) : 94-97.
  • 8Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosi.s. Clin Chem, 2002, 48(6 Pt 1): 850-858.
  • 9Perlemoine C, Beauvieux MC, Rigalleau V, et al. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism, 2003, 52(10): 1258-1264.
  • 10Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal,2004, 18(1): 31-35.

共引文献178

同被引文献87

  • 1Xin Li,Hang Zhu,Peng Li,Qian Xin,Jie Liu,Wei Zhang,You-Hong Xing,Hao Xue.Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy[J].Journal of Geriatric Cardiology,2013,10(3):286-290. 被引量:21
  • 2李治国,周霞,张浩,齐丽荣.胱抑素C、同型半胱氨酸及N末端B型利钠肽原检测在老年慢性心力衰竭患者中的应用[J].中国老年学杂志,2014,34(11):3137-3138. 被引量:19
  • 3孙晓慧.血清胱抑素C测定在疾病监测中的应用[J].医学综述,2006,12(7):443-445. 被引量:46
  • 4Hojs R,Bevc S,Ekart R,et al.Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease[J].Clin Nephrol,2008,70(1):10-17.
  • 5Dzielinska Z,Januszewica A,Wiecek A,et al.Reduced kidney function estimateed by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease:association with homocysteine and other cardiovascular risk factors[J].Kidney Blood Press Res,2010,33(2):139-148.
  • 6Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lam in a degradation and aortic dilatation in apolipoprote in E-null mice[J].Circ Res,2005,96(3):368-375.
  • 7Moran A,Katz R,Smith NL,et al.Cystatin C concentration as a predictor of systolic and diastolic heart failure[J].J Card Fail,2008,14(1):19-26.
  • 8Turk V, Stoka V, Turk D.Cystatins: biochemical and structural; prop- erties,and medical relevance[J].Front Biosci,2008,13(5):780-786.
  • 9Taglieri N,Koenig W, Kaski JC,et al.Cystatin C and cardiovascular risk[J].Clinical Chemistry,2009,55(11):932-943.
  • 10Xie L,Terrand J,Xu B,et al.Tsaprailis G,Boyer J,Chen QM.Cystatin C increases in cardiac injury: a role in extraceUular matrix protein modulation[J].Cardiovasc Res,2010,87(4):28-35.

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部